Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|November 15, 2000

Study shows ePocrates helps reduce med errors

Study shows ePocrates helps reduce med errorsPhysicians who use the ePocrates qRx handheld clinical drug reference guide may be avoiding more than two million adverse drug events annually, according to data extrapolated from a study presented

Study shows ePocrates helps reduce med errors

Physicians who use the ePocrates qRx handheld clinical drug reference guide may be avoiding more than two million adverse drug events annually, according to data extrapolated from a study presented at the annual meeting of the American Medical Informatics Association. Investigators at Brigham and Women's Hospital in Boston conducted a seven-day online survey of ePocrates users during March. Some 870 physicians participated via e-mail; of these, 50% indicated that the qRx helped them avoid one or more adverse drug events per week. qRx was launched last November and is now used by more than 80,000 physicians, according to the company.

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.